These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19445560)

  • 21. Efficacy and safety of drugs for ulcerative colitis.
    Rosenberg LN; Peppercorn MA
    Expert Opin Drug Saf; 2010 Jul; 9(4):573-92. PubMed ID: 20377475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children.
    Ziring DA; Wu SS; Mow WS; Martín MG; Mehra M; Ament ME
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):306-11. PubMed ID: 17873742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine for severe ulcerative colitis.
    Pham CQ; Efros CB; Berardi RR
    Ann Pharmacother; 2006 Jan; 40(1):96-101. PubMed ID: 16368919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
    Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
    Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
    Wenzl HH; Petritsch W; Aichbichler BW; Hinterleitner TA; Fleischmann G; Krejs GJ
    Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.
    Shen J; Ran ZH; Tong JL; Xiao SD
    Aliment Pharmacol Ther; 2007 Sep; 26(5):653-63. PubMed ID: 17697199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
    Iizuka M; Itou H; Konno S; Shirasaka T; Horie Y; Shindo K; Watanabe S
    Gut; 2006 Oct; 55(10):1523. PubMed ID: 16966708
    [No Abstract]   [Full Text] [Related]  

  • 30. Review article: the management of mild to severe acute ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():88-92. PubMed ID: 15352901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
    Adler DJ; Korelitz BI
    Am J Gastroenterol; 1990 Jun; 85(6):717-22. PubMed ID: 1972315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
    Okamura S; Aoki H; Ohashi S; Urano F; Shimodaira M; Kanamori S; Ishikawa H; Segawa K
    Hepatogastroenterology; 2003; 50(49):91-4. PubMed ID: 12629999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of acute severe ulcerative colitis.
    Doherty GA; Cheifetz AS
    Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of cytokines on suppression of lymphocyte proliferation by dexamethasone.
    Creed TJ; Lee RW; Newcomb PV; di Mambro AJ; Raju M; Dayan CM
    J Immunol; 2009 Jul; 183(1):164-71. PubMed ID: 19542427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data.
    Lynch RW; Churchhouse AM; Protheroe A; Arnott ID;
    Aliment Pharmacol Ther; 2016 Jun; 43(11):1132-41. PubMed ID: 27060985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ORGANIZED PNEUMONIA IN A PATIENT WITH ULCERATIVE COLITIS].
    Mikhailova SF; Denisenko OA
    Eksp Klin Gastroenterol; 2015; (8):105-9. PubMed ID: 27017753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse steroids for ulcerative colitis: good news, bad news, and no news.
    Sachar DB
    J Clin Gastroenterol; 2002 Oct; 35(4):291-2. PubMed ID: 12352289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.